Business Standard

USFDA conducts inspection of Lupin's Mandideep Unit-1

Image

Capital Market

Issues eight observation under Form 483

Lupin announced that the U.S. FDA inspected Lupin's Mandideep Unit-1 facility from 14 November 2022 to 23 November 2022. The inspection of the facility closed with issuance of a Form 483 with eight observations each for the Drug Product facility and API facility at the site.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 24 2022 | 6:53 PM IST

Explore News